BEMRIST BREEZHALER®


Powder for Inhalation
scheduling status
S4
registration number
54/10.2.1/0870.867; 54/10.2.1/0871.868; 54/10.2.1/0872.869
What BEMRIST BREEZHALER® contains
BEMRIST BREEZHALER 150/80 micrograms, contains 173 micrograms of indacaterol acetate equivalent to 150 micrograms of indacaterol and 80 micrograms of mometasone furoate. BEMRIST BREEZHALER 150/160 micrograms, contains 173 micrograms of indacaterol acetate equivalent to 150 micrograms of indacaterol and 160 micrograms of mometasone furoate. BEMRIST BREEZHALER 150/320 micrograms, contains 173 micrograms of indacaterol acetate equivalent to 150 micrograms of indacaterol and 320 micrograms of mometasone furoate.
other ingredients
Capsule fill: Lactose (as monohydrate). Capsule shell components: Gelatin.
Therapeutic classification
Long-acting inhaled therapy (beta-agonists and glucocorticosteroids).
© 2026 SAHPRA. ALL RIGHTS RESERVED